The dashboard by METANOVA Labs tracks drug discovery on Bittensor’s Subnet 68. focusing on molecular design, with the best molecule from Epoch 14606 scoring -1.8737. indicating high binding affinity for the target protein.
The NOVA dashboard reflects the application of Bittensor’s decentralized AI network to drug discovery, which incentivizes global miners to optimize molecular structures through $TAO tokens, dramatically reducing the time and cost of traditional drug discovery. According to Python.org (web ID: 1), traditional drug discovery takes an average of 10 years and costs up to $800 million, while decentralized approaches dramatically increase efficiency through collaboration and AI-driven molecular design.
for their contributions, highlighting the collaborative benefits of a decentralized ecosystem.
NOVA 💊⚡️ official dashboard is now live 🔥🔥🔥
— METANOVA (@metanova_labs) April 1, 2025
you can now find details on each challenge by epoch on our website or https://t.co/S9pZ4OwUrh
learn more about the featured protein targets, anti-targets, molecule submissions, active participants, and miner leaderboard
s/o to… pic.twitter.com/907Ma0p8Dy
The Shannon update, mentioned in the post, refers to an upcoming Bittensor protocol upgrade aimed at enhancing subnet efficiency, building on historical data from March 30. 2025. to refine AI-driven drug design.
